Title X Funding Restored, but New Rules Raise Concerns

Follow Drugslib on

By HealthDay Staff HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 10, 2026.

via HealthDay

FRIDAY, April 10, 2026 — Federal funding for reproductive health clinics is back on track, but some new rules appear to stray from the original goals.

Clinics that rely on the Title X program have now received their funding after the Trump administration delayed the application process.

The program supports care for more than 2.8 million low-income and uninsured patients.

The U.S. Department of Health and Human Services (HHS) delayed the usual application timeline, giving clinics just one week to apply starting March 13.

Funding typically renews April 1, but many clinics were left unsure about their budgets until grant awards were released days later.

“Generally speaking, grantees received awards that were level or approximately level with the allocation they received in 2025,” Clare Coleman, CEO of the National Family Planning and Reproductive Health Association, told NBC News.

The Title X program helps fund services such as birth control, cancer screenings, wellness exams and HIV testing.

At the same time, new guidelines for 2027 funding are drawing some attention.

The updated guidance places more focus on "natural family planning," which involves tracking menstrual cycles instead of using medications, NBC News reported.

“We expect applicants to demonstrate how their Title X projects will integrate noninvasive, evidence-based practices that promote health literacy, fertility awareness and reproductive health without unnecessary medicalization or symptom suppression,” the guidelines say.

But some experts say this could limit access to more reliable birth control methods.

“We are continuing to analyze the new guidance for the 2027 funding cycle and have concerns for what it means for patients,” said Ruth Richardson, president and CEO of Planned Parenthood North Central States.

Officials say the changes are meant to align with the adiministration's broader health goals.

“HHS is committed to ensuring Title X funds are not used for abortions consistent with the law and President Trump’s Executive Order on Enforcing the Hyde Amendment,” Emily Hilliard, a spokesperson for HHS, said.

The guidelines also raise concerns about what they describe as an "overreliance on pharmaceutical and surgical treatments."

Still, decades of research show that hormonal birth control is safe for most people, with serious risks considered rare.

The next round of funding applications is due in January, and clinics are still reviewing how the new rules could affect future offerings.

The government said it plans to make up to $257 million available through Title X for 2027, down from about $286 million in recent years.

Sources

  • NBC News, April 9, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-04-11 01:45

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords